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Lactococcin 972 (Lcn972) is a non- pore forming bacteriocin with a narrow spectrum of 
activity restricted to Lactococcus. Lcn972 inhibits the incorporation of cell wall 
precursors in the septum area, thereby inhibiting cell division. In this work, an 
additional inhibitory effect is described, namely, the induction of the lytic cycle of 
resident prophages in the lysogenic strain L. lactis IPLA 513. Lcn972 triggered the 
release of prophages in a concentration-dependent fashion. The extent of prophage 
induction was influenced by the physiological status of the cultures, being maximal at 
the early exponential growth phase. A microtiter based protocol was designed and the 
induction ability of several antimicrobials was compared. Prophages were activated by 
all cell wall biosynthesis inhibitors tested, although the levels of induction were lower 
than those obtained after activation of the SOS response. As far as we know, this is the 
first report of prophage induction by an antimicrobial peptide. Since Lcn972 is active 
against L. lactis strains currently used in commercial starters, promising applications for 
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Lactococcus lactis is widely used in the production of dairy products and is the main 
component of the starter cultures used in cheese manufacture. The key function of L. 
lactis as a starter is to produce enough lactic acid through the fermentation of lactose, 
the main carbohydrate of milk. This leads to a pH decrease relevant for milk clotting 
and for preventing spoilage and/or pathogen development. L. lactis also contributes 
greatly to the textural and organoleptic quality of the fermented products by the 
synthesis of flavour compounds and texturing agents. The hygienic quality is also 
enhanced by the production of several antimicrobial compounds, including bacteriocins 
(Mäyra-Mäkinen and Bigret, 2005). Therefore, the fermentation process relies, 
basically, on the optimal performance of the starter. 
One of the major leading causes of food fermentation failures is the presence of 
phages. Prophages in Lactococcus seem to be quite common and many strains possess 
one or more prophages integrated in their genome (Bolotin et al. 2001; Ventura et al. 
2007). Prophages may be induced under several stress conditions. The most studied is 
the activation of the SOS response by DNA damage. However, other environmental 
conditions were shown to activate the lytic cycle of temperate phages although the 
molecular pathways remain largely unknown for phages infecting L. lactis (Feirtag and 
McKay, 1987; Lunde et al. 2005; Meijer et al. 1998). 
Bacteriocins are ribosomally synthesised antimicrobial peptides which usually kill 
the target bacteria by forming pores in the cytoplasmic membrane (for a review see 
Cotter et al. 2005). Bacteriocin production is a common feature among lactic acid 
bacteria and bacteriocin producers are often isolated from dairy products (Cleveland et 
al. 2001; Stiles, 1996). Lactococcin 972 is a non-modified 66-aa hydrophilic bacteriocin 
















LAB bacteriocins described so far, Lcn972 does not form pores in the cytoplasmic 
membrane of susceptible cells. Cells treated with Lcn972 do not suffer either leakage of 
cytoplasmic solutes or significant inhibition of their macromolecular synthesis. 
However, incorporation of cell wall precursors in actively growing cells shifts from an 
exponential to a linear mode and subsequently becomes arrested (Martínez et al. 1996, 
2000). Treated cells suffer a gross change in cell size and shape and no septum is 
formed. Recently, it has been demonstrated that Lcn972 tightly binds to the cell wall 
precursor lipid II (Martínez et al. 2008).
While it is widely recognized that bacteriocin production may enhance the hygienic 
quality of the fermented products by inhibiting undesirable bacteria, little is known 
about putative adverse effects on starter performance. In this work we have assayed the 
ability of the Lcn972 to induce prophages in L. lactis. We show that Lcn972 and other 
cell wall antimicrobials act as prophage inducers in a concentration dependent fashion 
in early exponentially growing L. lactis.  
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2.1. Bacterial strains and culture conditions. 
Lactococcus lactis IPLA 513 (Cuesta et al. 1995) and L. lactis MG1614 (Gasson, 
1983) were used as lysogenic and phage susceptible strains, respectively. L. lactis 
strains from commercial starters were previously isolated by Madera et al. (2004). The 
lysogenic L. lactis IMN-C1814 carrying ΦLC3 as a prophage (Lunde et al., 2003) was 
kindly provided by I.F. Nes (Agricultural University of Norway). Cultures were grown 
in M17 broth (Scharlab, Barcelona, Spain) supplemented with 0.5% (v/v) glucose 
(GM17) at 32 °C. Stock cultures were maintained at -80 °C in broth containing 20% 
(v/v) glycerol and propagated from an isolated colony before each experiment. 
 
2.2. Bacteriocin purification and quantification. 
Lactococcin 972 (Lcn972) was extracted from supernatants of late exponential phase 
cultures of L. lactis IPLA 972 as previously described (Martínez et al. 1996). The 
bacteriocin activity was quantified by the agar diffusion test. Twofold serial dilutions of 
Lcn972 in 50 mM sodium phosphate buffer, pH 6.8, were tested. The antimicrobial 
activity was defined as the reciprocal of the highest dilution that produced a clear zone 
of growth inhibition on the indicator lawn (Arbitrary Units, AU/ml). 
 
2.3. Minimum Inhibitory Concentration (MIC). 
The susceptibility of L. lactis strains was determined by the agar diffusion test as 
described in 2.2. Plates were inoculated with 105 cfu/ml from overnight cultures. MICs 





























The lysogenic strain L. lactis IPLA 513 was grown to the early exponential phase 
(Optical Density, OD600 nm=0.2) in GM17 broth. Cells were washed with ¼ Ringer 
solution (Merck, Damstadt, Germany) and resuspended in the same volume of fresh 
broth. Different concentrations of Lcn972 were added, followed by further incubation at 
32 ºC for 2 h. Samples were taken and the evolution of viable bacteria and the 
production of a viral progeny were determined. Viable cells were enumerated on GM17 
agar 2%. Culture supernatants were sterilized by using 0.2-µm-pore-diameter cellulose 
acetate filters (VWR International, Barcelona, Spain). For plaque assays, serial dilutions 
of the supernatants were mixed with 100 µl of an overnight culture (109 cfu/ml) of the 
sensitive strain L. lactis MG1614 in top GM17 agar 0.7% and immediately poured onto 
GM17 plates containing 10 mM CaCl2 and 10 mM MgSO4. The plates were inspected 
for plaques of lysis after incubation for 24 h at 32 ºC. To test prophage induction from 
cells at different physiological status, L. lactis IPLA 513 was grown at the desired 
OD600 nm, namely, at 0.2 (early-), 1.0 (middle-) and 2.0 (late-exponential growth phase). 
Cells were collected, washed and adjusted to an OD600 nm of 0.2 in fresh broth in order 
to treat the same number of cells with Lcn972 (20 AU/ml), independently of the initial 
OD of the culture. Controls without Lcn972 were also carried out. Prophage induction 
factor was defined as pfu/ml of treated culture divided by pfu/ml of untreated culture. 
 
2.5. Microtiter-based prophage induction. 
Mitomycin C, bacitracin, penicillin G, chloramphenicol and mutanolysin were 
purchased from Sigma-Aldrich (St Louis, MO, USA) and lysozyme from USB 
(Cleveland, OH, USA). Plantaricin C was purified as previously described (Wiedemann 
et al. 2006). Stocks were made fresh in sterile distilled water at four-times the desired 
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concentration: 2 mg/ml for lysozyme, 40 µg/ml for bacitracin and mutanolysin, 20 
µg/ml for chloramphenicol, 10 µg/ml for plantaricin C, and 2 µg/ml for penicillin G. 
100 µl aliquots were dispensed in the microtiter wells containing 100 µl of GM17 broth 
and twofold dilutions were made. The microtiter plates were inoculated with 100 µl of 










600 nm=0.2. Plates were 
incubated at 32 ºC and the OD600 nm was monitored every 15 min in a Benchmark 
Microtiter plate reader (BioRad Laboratories, Hercules, CA, USA). After 210 min, the 
plates were centrifuged for 10 min at 1000 xg to collect the supernatants. Phage release 
was quantified by the plaque assay.  
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Defective cell wall synthesis was revealed as an inducer of the bacterial SOS 
response in E. coli (Miller et al. 2004). A well-known consequence of the activation of 
the SOS response is the activation of prophages (Little and Mount, 1982). Our 
hypothesis was that cell wall synthesis inhibition by Lcn972 might trigger a similar 
response and, thereby, Lcn972 could behave as a prophage inducer in L. lactis. 
Viable phages were detected in the supernatants of early exponentially growing 
cultures of the lysogenic strain L. lactis IPLA 513 after treatment with Lcn972 (Fig. 1). 
The number of infecting virions correlated well with the increasing concentrations of 
Lcn972. Prophage induction became evident at Lcn972 concentrations of 20 AU/ml and 
over. Below this threshold, phage numbers around 3.3±0.1 log pfu/ml, which would 
correspond to the spontaneous induction levels, were found. 
The extent of Lcn972-mediated prophage induction was also tested on cells from 
middle and late exponential growth phase (Table 1). Under these conditions, no effect 
of Lcn972 was observed. Similar phage numbers were detected in the supernatants of 
treated and control cultures as revealed by induction factors close to 1. The lack of 
phage induction at these growth stages could be related to the lower antimicrobial 
activity of Lcn972 against late exponentially growing cells (Martínez et al. 2000). The 
loss of viability after Lcn972 treatment in middle and late exponential cells was half of 
that observed for early exponential cells (Table 1). It was also noted that the level of 
spontaneous induction was higher at the end of the exponential growth phase (data not 
shown). This has been already reported in the literature and thought to be due to a loose 
chromosomal status and a higher instability of the prophage genome integrated in it 
(Lunde et al. 2003). 
In additional experiments, phage induction by different antimicrobials was studied in 



























inducer mitomycin C was used as a reference. After treatment with this drug, induction 
factors of 102.75±20.9) were obtained, which are five times higher than those obtained 
by Lcn972 (data not shown). Induction factors similar to those achieved by Lcn972 
were obtained with other cell wall interacting antimicrobials such as the bacteriocin 
plantaricin C, and the antibiotics bacitracin and penicillin G (Fig. 2). Remarkably, 
prophage release was not observed after treatment of lysogenic cultures with the 
muramidases lysozyme and mutanolysin nor with the protein biosynthesis inhibitor 
chloramphenicol. The former antimicrobials have in common that they inhibit cell wall 
biosynthesis either by interfering with lipid II (PlnC and bacitracin) or by inactivating 
the penicillin-binding-proteins (PBPs) which carry out the ultimate transpeptidation 
steps. In contrast, lysozyme and mutanolysin hydrolyze the pre-existing cell wall. 
Therefore, it is tempting to speculate that the stimulus that induces temperate phage 
excision relies on the disturbance of the lipid II cycle. Recently, we have shown that 
Lcn972 activates the two component system CesSR that triggers the response of L. 
lactis to cell envelope stress (Martínez et al. 2007). One of the members of this regulon 
is the membrane-bound protease FtsH (or HflB) which is involved in regulating the 
lysogenic state of phage λ (Herman et al. 1997; Ito and Akiyama, 2005). Whether FtsH 
plays a similar role in L. lactis remains to be investigated. This molecular network could 
act independently of the bacterial SOS response and, based on our results, the signalling 
cascade would lead to a weaker induction compared to SOS.  
As far as we know, this is the first description of prophage release induced by a 
bacteriocin. This effect may be restricted to specific prophage/host systems because 
attempts to induce the prophage ΦLC3 present in L. lactis IMN-C1814 with Lcn972 
failed. Exponentially growing cultures of L. lactis IMN-C1814 were treated with 20 up 






















treated and control cultures (data not shown). On the contrary, mitomycin C effectively 
induced the prophage with induction factors of 20 to 40. Other lysogenic L. lactis 
strains should be tested to determine which prophages may be induced by Lcn972. 
The presence of bacteriophages is envisaged as detrimental to industrial 
fermentations due to premature lysis of the starters. However, it has also been suggested 
that lysogenic lactococcal strains and bacteriocin producers could be useful to promote 
programmed lysis of starter cells and the release of intracellular enzymes into the cheese 
matrix to accelerate ripening (Lepeuple et al. 1998; Morgan et al. 1996). It has been 
reported that Lcn972 inhibits several L. lactis strains (Martínez et al. 1996). Moreover, 
we have tested the susceptibility to Lcn972 of 16 representative strains isolated from 
commercial starters. The MICs ranged from 50 to 1600 AU/ml and, roughly, half of 
them were as susceptible as L. lactis IPLA513 (Table 2). Thus, the inclusion of the 
Lcn972 producer strain in starter formulations might be useful to promote starter lysis. 
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Figure 1. Prophage induction in early exponentially growing cultures of the lysogenic 
strain L. lactis IPLA 513 in response to increasing Lcn972 concentrations. Lcn972 was 
added to cultures at an OD600 nm=0.2 and incubated at 32 ºC. Viable cells (bars) and 
phage (line) counts are expressed as cfu/ml and pfu/ml, respectively. 
 
Figure 2. Prophage induction of L. lactis IPLA 513 by several antimicrobials. 
Exponentially growing L. lactis IPLA 513 cells were treated with different 
concentrations of PlnC (plantaricin C), Bac (bacitracin), PenG (penicillin G), Cm 
(chloramphenicol), Lys (lysozyme) and Mut (mutanolysin). Lcn972 was included as a 
positive control. Induction factors were calculated as pfu/ml in the treated samples 
divided by pfu/ml in the untreated samples. The inducer of the SOS response mitomycin 
C (0.5 µg/ml) was used and induction factors of 102.75±20.9 were achieved (data not 
shown). Values are mean of three experiments. Standard deviations are shown. 
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Table 1. Viability and prophage induction after 2 h treatment with Lcn972 of L. lactis 






Early exponential (0.2) 8.76 4.49 5.61 
Middle exponential (1.0) 8.72 6.09 1.55 
Late exponential (2.0) 8.66 6.09 1.38 
aCells from the different growth phases were adjusted to OD600nm=0.2 
that corresponds to 7.8 log cfu/ml. 
Table 2. Susceptibility to Lcn972 of L. lactis IPLA 513, L. lactis  MG1614 and several L. 







Starter 1 1.1 50 
Starter 5 5.1. 50 
Starter 6 6.1 50 
 6.2 25 
 6.3 50 
 6.4 50 
Starter 7 7.1 50 
 7.2 800 
 7.3 >3200 
Starter 8 8.1 1600 
 8.2 200 
Starter 9 9.1 400 
 9.2 200 
 9.3 800 
 9.4 800 
 9.5 200 
L. lactis IPLA 513 50 
L. lactis MG 1614 50 
aStrains from commercial starters were described 
by Madera et al. (2004). 
bMIC, Minimum Inhibitory Concentration; AU, 
Arbitrary Units. 
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